Skip to main content
. 2023 Jun 23;15(6):e40879. doi: 10.7759/cureus.40879

Table 3. Median survival of different subtypes of NTCCB in our study.

NTCCB: Non-transitional cell carcinoma of the bladder

NTCCB subtype Median survival (months)
Squamous cell carcinoma (n=14)
  Localized (n=8) 32
  Locally advanced (n=4) 13
  Metastatic (n=2) 12
Adenocarcinoma (n=13)
  Localized (n=2) 39
  Locally advanced (n=1) 15
  Metastatic (n=10) 11
Extra-adrenal phaeochromocytoma (n=1) 57
Neuroendocrine tumor (n=2) 10
Sarcomatoid carcinoma (n=1) 9